Dr. Reddys Laboratories (RDY)
(Delayed Data from NYSE)
$68.68 USD
-1.18 (-1.69%)
Updated May 31, 2024 04:00 PM ET
After-Market: $68.64 -0.04 (-0.06%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Brokerage Reports
Dr. Reddy's Laboratories Ltd [RDY]
Reports for Purchase
Showing records 81 - 100 ( 186 total )
Company: Dr. Reddy's Laboratories Ltd
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Dr. Reddy's Laboratories Ltd
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Dr. Reddy's Laboratories Ltd
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Dr. Reddy's Laboratories Ltd
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Dr. Reddy's Laboratories Ltd
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Dr. Reddy's Laboratories Ltd
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Dr. Reddy's Laboratories Ltd
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Dr. Reddy's Laboratories Ltd
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Dr. Reddy's Laboratories Ltd
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Dr. Reddy's Laboratories Ltd
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Dr. Reddy's Laboratories Ltd
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Dr. Reddy's Laboratories Ltd
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Dr. Reddy's Laboratories Ltd
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department